Physician profile
Usha Sadanala
NPI 1326308248
$2,113.20
in general payments reported to CMS, 2019-2025
18 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $743 · 2023: $482 · 2024: $568 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $821.48 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $242.30 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $223.65 | 2022-2025 | |
| Exact Sciences Corporation | $134.03 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $132.90 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $118.82 | 2022-2024 | |
| Abbvie INC. | $84.52 | 2023-2024 | Vraylar |
| Merck Sharp & Dohme LLC | $63.66 | 2022-2024 | Gardasil 9, Gardasil, Capvaxive |
| Amgen INC. | $58.20 | 2024-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.16 | 2025 | Ofev |
| Edwards Lifesciences Corporation | $39.33 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $31.10 | 2024 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $29.99 | 2022 | |
| Abbott Laboratories | $24.92 | 2023 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $19.66 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $16.89 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Idorsia Pharmaceuticals US INC | $15.16 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usha Sadanala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.